01 4SENTYNL THERAPS INC
01 27838531
02 28828356
01 4Blank
01 4Blank
01 22025-07-26
02 22025-10-17
Patent Expiration Date : 2025-10-17
US Patent Number : 8828356
Drug Substance Claim :
Drug Product Claim :
Application Number : 213969
Patent Use Code : U-3070
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-10-17
Patent Expiration Date : 2025-07-26
US Patent Number : 7838531
Drug Substance Claim :
Drug Product Claim :
Application Number : 213969
Patent Use Code : U-3070
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-07-26
Patent Expiration Date : 2025-07-26
US Patent Number : 7838531
Drug Substance Claim :
Drug Product Claim :
Application Number : 213969
Patent Use Code : U-3070
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-07-26
Patent Expiration Date : 2025-10-17
US Patent Number : 8828356
Drug Substance Claim :
Drug Product Claim :
Application Number : 213969
Patent Use Code : U-3070
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-10-17
LOOKING FOR A SUPPLIER?
